216
Views
9
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection

, , , , , , , & show all

References

  • Mitchell DH, Howden BP. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med J. 2005;35:S17–S24.
  • Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, Nimmo GR, et al.Staphylococcus aureus bacteremia: a major cause of mortality in Australia and New Zealand. Med J Aust. 2009;191(7):368–73.
  • van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of Mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362–86.
  • Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RCJr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42(6):2398–402.
  • Dhand A, Sakoulas G. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC creep’): implications for therapy. F1000 Med Rep. 2012;4:4.
  • Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010;23(1):99–139.
  • Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, et al.Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46(2):193–200.
  • van Hal SJ, Barbagiannakos T, Jones M, Wehrhahn MC, Mercer J, Chen D, et al.Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. J Antimicrob Chemother. 2011;66(10):2284–7.
  • Appleman MD, Citron DM. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years. Diagn Microbiol Infect Dis. 2010;66(4):441–4.
  • Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, et al.Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. Clin Microbiol Infect. 2013;19(11):1049–57.
  • Gasch O, Ayats J, Angeles Dominguez M, Tubau F, Liñares J, Peña C, et al.Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at the university hospital. Medicine (Baltimore). 2011;90(5):319–27.
  • Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis. 2009;48(Suppl 4):S231–7.
  • Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infection Disease Society of America. Clin Infect Dis. 2009;49(1):1–45.
  • Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, et al.Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentration. J Infect Dis. 2011;204(3):340–7.
  • Forstner C, Dungl C, Tobudic S, Mitteregger D, Lagler H, Burgmann H. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence. Clin Microbiol Infect. 2013;19(7):E291–7.
  • Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA. 2014;312(15):1552–64.
  • Chu VH, Sexton DJ. Telephone consultation for Staphylococcus aureus bacteraemia: opening Pandora's box. Clin Infect Dis. 2013;56(4):536–8.
  • Corcione S, Pagani N, Forni N, Di Perri G, De Rosa FG. Start smart with antimicrobial stewardship. Clin Infect Dis. 2015;61(6):1033–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.